Home
Movement
Investments
Education
Blog
Plans
Guardant Health Inc header image

Guardant Health Inc

GH

Equity

ISIN null / Valor 43633454

NASDAQ (2026-04-30)
USD 87.08+4.40%

Guardant Health Inc
UMushroom community rating:

star star star star star
4.29 7 votes No rating yet
NegativeNeutralPositive

About company

Guardant Health Inc is a company that focuses on utilizing blood tests to provide valuable insights for improving clinical outcomes in cancer care. With over 500,000 tests performed by 12,000 doctors, their commercially available tests assist in treatment decisions for advanced cancer patients, monitoring treatment response, detecting residual and recurrent disease in early-stage cancer patients, and potentially screening for cancer before symptoms appear. Additionally, their products support pharmaceutical companies in developing innovative cancer therapies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

84.4%1Y
286%3Y
-45.2%5Y

Performance

55.6%1Y
63.2%3Y
68.6%5Y

Volatility

Market cap

11422 M

Market cap (USD)

Daily traded volume (Shares)

2,708,422

Daily traded volume (Shares)

1 day high/low

31.2 / 29.98

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.29

7 votes
Performance:
starstarstarstarstar
4.43
Innovation:
starstarstarstarstar
4.57
Society:
starstarstarstarstar
4.57
Nature:
starstarstarstarstar
4.14
Luba Schoenig
Switzerland, 01 Nov 2022
star star star star star
Lea Katunaric
Switzerland, 01 Nov 2022
star star star star star
Laura Bischofberger
Switzerland, 01 Nov 2022
star star star star star
Promissing news release regarding fight cancer.

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%EUR 24.14
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.09%EUR 68.70
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.51%USD 326.48
Universal Health Services Inc
Universal Health Services Inc Universal Health Services Inc Valor: 982101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.18%USD 168.27
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%USD 13.64
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%USD 25.94
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.54%USD 100.00
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.83%EUR 7.80
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%USD 24.69
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.59%USD 1.70
SIXFactSetClearbitLogos provided by Clearbit